Big Apple NETs_0

September Luncheon with the Experts in NYC for Carcinoid and Neuroendocrine Tumor Patients

August 16, 2015

Carcinoid and neuroendocrine tumor (NET) patients are invited to join three medical experts for Lunch with the Experts in New York City on Sunday, September 27, 2015 at 12:30 pm. This special program was initiated and is sponsored by the Big Apple NETs

READ MORE
Survey, online, feedback

Help Us to Help You: New Survey for the Carcinoid and Neuroendocrine Tumor Community

August 13, 2015

The Carcinoid Cancer Foundation is always looking at ways of improving content and services available to people living with carcinoid cancer and other neuroendocrine tumors and we are working with a pharmaceutical partner,Ipsen, to better understand…

READ MORE

Lexicon’s Carcinoid Syndrome Treatment Meets Primary Endpoint in Phase III Clinical Trial

August 5, 2015

Lexicon Pharmaceuticals Inc. has announced that the pivotal phase III clinical trial, TELESTAR, of its oral drug candidate telotristat etiprate met the primary endpoint in treating cancer patients with carcinoid syndrome that is not adequately controlled…

READ MORE
CME, Emerging Therapies for Neuroendocrine Tumors_New Perspectives for Oncology Nurses

Educational Program for Oncology Nurses on Emerging Therapies for Neuroendocrine Tumors

August 2, 2015

“Emerging Therapies for Neuroendocrine Tumors: New Perspectives for Oncology Nurses,” is an educational program jointly provided by the Postgraduate Institute for Medicine and the Center of Excellence Media, LLC. The program, offered through June

READ MORE
Warner Advocacy Award

Call for Nominations: 6th Annual Warner Advocacy Award

July 30, 2015

Do you know someone who is a passionate advocate for patients with neuroendocrine tumors (NETs)? Novartis Oncology and The NET Alliance are searching for an outstanding NET patient advocate to recognize and honor with the 6th Annual Warner Advocacy

READ MORE

Surviving Carcinoid Cancer for More Than 3 Decades

July 14, 2015

Marilyn Thurston of Colorado may be the longest-surviving carcinoid patient in the United States and possibly the world, having been diagnosed over 30 years ago.  Her physician, Dr. Nicholas DiBella, created a special pin recognizing her tenacity.…

READ MORE
Michael Farris, Fox 4 TV coverage

Denied: Michael Farris’ Journey with Insurance for Neuroendocrine Cancer Treatment

June 10, 2015

The good news is the very positive result at the end – but the road to getting insurance coverage for Michael Farris’ participation in the PRRT (peptide receptor radionuclide therapy) clinical trial at Excel Diagnostics in Houston, Texas, was fraught…

READ MORE
Jaswinder Samra, PNETs and Role of Lymph Nodes

CNETS Singapore Presents New Webinar Series Featuring Neuroendocrine Cancer Experts

April 22, 2015

The Carcinoid & Neuroendocrine Tumor Society (CNETS) of Singapore is embarking on a series of webinars on various topics related to the diagnosis and treatment of neuroendocrine cancers. With the support of a grant fromIpsen Biopharmaceuticals

READ MORE

Celebrating Carcinoid/NET Physicians on National Doctors’ Day

March 29, 2015

March 30 is NATIONAL DOCTORS’ DAY. In recognition of carcinoid/neuroendocrine tumor (NET) doctors – you are our heroes and superheroes!! Pictured are some of the NET specialists throughout the United States.

Pictured by columns, left to right, top …

READ MORE

First Northeastern Facility Offers Gallium-68 DOTATOC PET/CT Imaging for Carcinoid and Neuroendocrine Cancer Patients

February 9, 2015

When Brian Hakimian had the 68Gallium DOTATOC PET/CT scan at the Icahn School of Medicine, Mount Sinai in New York City on January 14, 2015, he became the first carcinoid patient to undergo this novel imaging test at a northeastern facility. Now in clinical…

READ MORE